![]() | Only 14 pages are availabe for public view |
Abstract Epilepsy is one of the most common serious neurological disorders characterized by seizures or vigorous shaking that can be very short and nearly undetectable or may last for long periods of time. Epileptic seizures have no immediate underlying cause, some occurring due to brain pathology (injury, stroke, tumors, infections), genetic mutations or birth defects through epileptogenesis with a long term risk of recurrent seizures. It occur due to excessive and abnormal nerve cell activity in the brain cortex. Diagnosis of epilepsy is helped but not necessarily ruled out by brain imaging and confirmed by an electroencephalogram. Antiepileptic drugs are the cornerstone of epilepsy treatment. The aim of treatment is to get rid of seizures, no side effects and a good quality of life for patient. However, AEDs are known to cause a wide range of side effects, including hematological changes. These have been implied on the older AEDs, but clinical experience for the more recent AEDs is currently insufficient to draw robust conclusions. Valproic acid is abroad spectrum antiepileptic drug and one of the most frequently prescribed drugs for the therapy of generalized and focal epilepsies. Valproate induces a variety of hemostatic disorders such as thrombocytopenia, abnormal platelet function, decreased concentrations of von Willebrand factor, and hyperfibrinogenemia .It rarely causes serious bleeding complications. It may also lead to atherosclerosis and thrombosis. However, there is still shortage of knowledge about the incidence and occurrence of these particular side effects. VPA also has effect on some procoagulant proteins, (protein C and S).Protein C and protein S activities were found to below among children |